Neurogen
Regenerative Therapeutics & Tissue-Based Neural Restoration
Neurogen Global Pty Ltd is a Melbourne-based neurotechnology and biotechnology company developing advanced tissue-based biological brain implants to address structural disruption of neural circuitry in neurodegenerative diseases such as Alzheimer’s and Parkinson’s Diseases. The approach centres on reconstructing functional architecture within the brain, moving beyond pharmacological symptom management toward direct repair of neural systems.
The Mission
To establish clinically viable pathways for restoring brain function in neurodegenerative diseases.
Technical Core
Stem cell–derived microtissue systems designed to integrate with host neural networks and support structural and functional recovery.
Scientific Edge
Focus on cortical cytoarchitecture and network-level integration to enhance survival, connectivity, and long-term functionality of implanted tissue.
Nova-Intelligence Network
Advancing biological intelligence in the AI-driven world
he Nova Intelligence Network is a global, non-profit initiative focused on advancing biological intelligence to meet the demands of rapidly evolving artificial systems. It brings together researchers, professionals and technologists across neuroscience, genetics, physics, engineering and advanced technologies to investigate the mechanisms that underlie human cognition and its potential to accelerate the rate of evolution.
The Mandate
To identify and support strategies that accelerate the evolution of human biological intelligence while preserving the fundamental essence of humanity.
Strategic Scope
Partner research focus includes cortical microcircuitry, synaptic plasticity, and quantum-inspired neural modelling to develop frameworks for human-machine augmentation and cognitive optimisation.
The Vision
To build an intelligent and humane society where biological capability is intentionally accelerated to meet the demands of a post-AI future.
Cooray Venture Foundry (The Foundry)
Translating innovation into globally scalable ventures
The Cooray Venture Foundry (The CVF; The Foundry) is an Australian-based venture studio focused on supporting biotech, medtech, and health innovation emerging from Sri Lanka. It provides a structured pathway to identify high-potential ideas, validate market relevance, strengthen intellectual property strategy, and prepare ventures for international growth.
The Foundry operates at the interface of local innovation and global commercialisation. Its role is to help founders move from a technical concept to the formation of an investable company through targeted advisory, early seed support, access to mentors, and venture-building guidance, and along the go-to-market pathway, navigating through a successful exit.
Founding Legacy
Established in memory of late parents, Nilmini and Jayalal Cooray, The CVF continues the family legacy of empowerment through education and contribution to the global community.
The Model
The CVF identifies groundbreaking innovations developed within Sri Lanka. Working with the innovators, The CVF bridges the local innovation with global expertise, capital networks, and regulatory frameworks.
Operational Impact
The Foundry provides early-stage validation, strategic advisory, investor readiness, regulatory pathway assessment, and targeted seed support where appropriate. These structured investment pathways and early seed support ensure that impactful innovations are not constrained by geography or institutional boundaries.
Strategic Innovation Tracks
Translational BioTech:
Focuses on biotechnology, neurotechnology, diagnostics and therapeutics requiring scientific validation, intellectual property development, rigorous clinical and regulatory planning.
Health Tech & Deep Tech:
Focuses on digital health, AI-enabled healthcare tools, medical devices, and platform technologies requiring technical validation, market strategy, and scalable venture architecture.
Dr Ruwini Cooray 